SODIUM P.A.S Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sodium P.a.s, and when can generic versions of Sodium P.a.s launch?
Sodium P.a.s is a drug marketed by Lannett and is included in one NDA.
The generic ingredient in SODIUM P.A.S is aminosalicylate sodium. There are three drug master file entries for this compound. Additional details are available on the aminosalicylate sodium profile page.
Summary for SODIUM P.A.S
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SODIUM P.A.S at DailyMed |
US Patents and Regulatory Information for SODIUM P.A.S
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lannett | SODIUM P.A.S. | aminosalicylate sodium | TABLET;ORAL | 080138-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |